---
title: "XI'AN GLOBAL: Hong Kong Yuan Stone plans to reduce its holdings by no more than 1% of its shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/239578953.md"
description: "According to the Zhitong Finance APP, XI'AN GLOBAL announced that Hong Kong Original Stone plans to reduce its holdings of the company's shares by no more than 3.2004 million shares through centralized bidding transactions, accounting for 1% of the company's total share capital"
datetime: "2025-05-09T13:03:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239578953.md)
  - [en](https://longbridge.com/en/news/239578953.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239578953.md)
---

# XI'AN GLOBAL: Hong Kong Yuan Stone plans to reduce its holdings by no more than 1% of its shares

According to the announcement from Dolphin Research, XI'AN GLOBAL (002799.SZ) stated that Hong Kong Original Stone plans to reduce its holdings of the company's shares by no more than 3.2004 million shares through centralized bidding transactions, accounting for 1% of the company's total share capital

### Related Stocks

- [002799.CN](https://longbridge.com/en/quote/002799.CN.md)

## Related News & Research

- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [PetroTal Announces Availability of Annual General Meeting Materials | PTALF Stock News](https://longbridge.com/en/news/287013425.md)
- [11:48 ETInventHelp Inventor Develops New Remote Control Finder (TKA-458)](https://longbridge.com/en/news/286941635.md)
- [08:28 ETTERREPOWER Demonstrates Decarbonization and Resource Efficiency at Scale in 2025 Corporate Sustainability Report](https://longbridge.com/en/news/286912255.md)
- [4basebio signs clinical supply agreement for Phase II immunotherapy trial opDNA material](https://longbridge.com/en/news/287052696.md)